Journal of Medicinal Chemistry, volume 56, issue 20, pages 8112-8138
Synthesis and Biological Evaluation of 8-Aminomethyltetracycline Derivatives as Novel Antibacterial Agents
Roger B. Clark
1
,
Minsheng He
1
,
Yonghong Deng
1
,
Cuixiang Sun
1
,
Chi-Li Chen
1
,
Diana K Hunt
1
,
William J. O??Brien
1
,
Corey Fyfe
1
,
Trudy H Grossman
1
,
Joyce A Sutcliffe
1
,
Catherine Achorn
1
,
Philip C Hogan
1
,
Christopher E Katz
1
,
John Niu
1
,
Wu-Yan Zhang
1
,
Zhijian Zhu
1
,
Magnus Rönn
1
,
Xiao-Yi Xiao
1
1
Discovery Chemistry, ‡Microbiology, and §Process Chemistry R&D, Tetraphase Pharmaceuticals, Inc., 480 Arsenal Street, Watertown, Massachusetts 02472, United States
|
Publication type: Journal Article
Publication date: 2013-10-03
Journal:
Journal of Medicinal Chemistry
scimago Q1
SJR: 1.986
CiteScore: 12.8
Impact factor: 6.8
ISSN: 00222623, 15204804
PubMed ID:
24047201
Drug Discovery
Molecular Medicine
Abstract
The C-8 position of the tetracyclines has been largely underexplored because of limitations in traditional semisynthetic techniques. Employing a total synthetic approach allowed for modifications at the C-7 and C-8 positions, enabling the generation of structure-activity relationships for overcoming the two most common tetracycline bacterial-resistance mechanisms: ribosomal protection (tet(M)) and efflux (tet(A)). Ultimately, several compounds were identified with balanced activity against both Gram-positive and Gram-negative bacteria, including pathogens bearing both types of tetracycline-resistance mechanisms. Compounds were screened in a murine systemic infection model to rapidly identify compounds with oral bioavailability, leading to the discovery of several compounds that exhibited efficacy when administered orally in murine pyelonephritis and pneumonia models.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.